INFLUENCE OF CRYSTALLIZATION SOLVENT AND DISSOLUTION BEHAVIOR FOR A DICLOFENAC SALT

被引:12
作者
FINI, A
FAZIO, G
FERNANDEZHERVAS, MJ
HOLGADO, MA
RABASCO, AM
机构
[1] UNIV SEVILLA,FAC FARM,DEPT FARM & TECNOL FARMACEUT,E-41012 SEVILLE,SPAIN
[2] UNIV BOLOGNA,IST SCI CHIM,I-40127 BOLOGNA,ITALY
关键词
DICLOFENAC N-(2-HYDROXYETHYL)PYRROLIDINE SALT; SCANNING ELECTRON MICROSCOPY; THERMAL ANALYSIS; DISSOLUTION EFFICIENCY; SHAPE FACTOR;
D O I
10.1016/0378-5173(94)00419-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
11 samples of diclofenac/N-(2-hydroxyethyl)pyrrolidine salt obtained by crystallization from alcohol-type solvents or mixtures with triacetin were analyzed by scanning electron microscopy and differential scanning calorimetry. Few differences were found concerning the size parameters of particles obtained from different solvents, while the shape parameters displayed major differences depending on the crystallization solvent. Most of the samples showed simple thermograms while in the case of those obtained from isopropanol and 1,3-butanediol, the presence of the solvent inside the mass of the crystals was recorded. Dissolution profiles were found to be different for all the samples (due also to different sizes of the dissolving particles). An interesting linear relationship was found between the efficiency of dissolution and the shape factor of the dissolving particles, suggesting the relevant importance of shape irregularity in affecting dissolution rate differences.
引用
收藏
页码:19 / 26
页数:8
相关论文
共 9 条
[1]   REACTIVE FRACTAL SURFACES [J].
FARIN, D ;
AVNIR, D .
JOURNAL OF PHYSICAL CHEMISTRY, 1987, 91 (22) :5517-5521
[2]   USE OF FRACTAL GEOMETRY TO DETERMINE EFFECTS OF SURFACE-MORPHOLOGY ON DRUG DISSOLUTION [J].
FARIN, D ;
AVNIR, D .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (01) :54-57
[3]   USE OF FRACTAL GEOMETRY ON THE CHARACTERIZATION OF PARTICLES MORPHOLOGY - APPLICATION TO THE DICLOFENAC HYDROXYETHYLPIRROLIDINE SALT [J].
FERNANDEZHERVAS, MJ ;
HOLGADO, MA ;
RABASCO, AM ;
FINI, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 108 (03) :187-194
[4]  
FINI A, 1991, PHARM ACTA HELV, V66, P201
[5]  
FINI A, 1994, FARMACO, V49, P141
[6]  
FINI A, 1994, ACTA TECHNOL LEG MED, V5, P13
[7]  
FINI A, 1994, ATTI ACCAD SCI IST B, V14, P175
[8]   CHARACTERIZATION STUDY OF A DICLOFENAC SALT BY MEANS OF SEM AND FRACTAL ANALYSIS [J].
HOLGADO, MA ;
FERNANDEZHERVAS, MJ ;
RABASCO, AM ;
FINI, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 120 (02) :157-167
[9]   STUDIES ON SOME CRYSTALLINE FORMS OF IBUPROFEN [J].
LABHASETWAR, V ;
DESHMUKH, SV ;
DORLE, AK .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1993, 19 (06) :631-641